Cobalamin and folate, also known as vitamin B12 and vitamin B9, respectively, are crucial for rapid cell division and anabolic processes, as well as for the synthesis of DNA(Reference van de Rest, van Hooijdonk and Doets1). In addition, both have essential roles in the central nervous system and in the methylation cycle(Reference Mahmood2,Reference Varela-Moreiras, Murphy and Scott3) , and deficiency in either micronutrient can lead to megaloblastic anaemia(Reference Koury and Ponka4,Reference Stabler5) . Overt deficiency and suboptimal status of these two vitamins are major public health concerns affecting a large number of people across all ages worldwide(Reference de Benoist6–Reference Smith, Warren and Refsum8).
During pregnancy and lactation, women have a higher risk of deficiency due to an increased demand for vitamin B12 and folate(Reference Sukumar, Rafnsson and Kandala9–Reference Smith, Picciano and Deering11). In a meta-analysis including fifty-seven studies from across the globe, it was estimated that one-fourth of all pregnant women were cobalamin-deficient across all trimesters of pregnancy(Reference Sukumar, Rafnsson and Kandala9). In the four studies from the Indian subcontinent included in this meta-analysis, 32 % of women were defined as cobalamin-deficient in their first trimester, and 64 % in the second trimester. Both maternal vitamin B12 deficiency and folate deficiency have been associated with an increased risk of complications and poorer outcomes in pregnancy(Reference Liu, Liu and Wang12–Reference Mobasheri, Keshtkar and Golalipour20) as well as long-term consequences such as impaired postnatal growth and cognitive development(Reference Strand, Ulak and Kvestad21–Reference Molloy, Kirke and Brody25).
Total homocysteine (tHcy) and methylmalonic acid (MMA) are functional biomarkers of vitamin B12 status, both increasing with decreasing cobalamin concentration. While MMA is a specific indicator of cobalamin, tHcy is influenced by other factors, in particular folate status(Reference Finkelstein, Layden and Stover17,Reference Stabler26) . A combined indicator of vitamin B12 has been proposed which includes both direct and functional biomarkers, namely cobalamin, MMA, tHcy and holotranscobalamin(Reference Fedosov, Brito and Miller27).
The most direct causes of vitamin B12 and folate deficiency are related to the diet and to malabsorption(Reference Allen28). Biologically active cobalamin is only found in animal-derived foods, while folate is most abundant in green leafy vegetables, legumes and some fruits. Therefore, vegetarians are at higher risk of a vitamin B12 deficiency(Reference Allen28,Reference Villamor, Mora-Plazas and Forero29) , and populations consuming diets low in fresh fruits, vegetables and cereals are at greater risk of folate deficiency(Reference Carmel, Shils, Shike, Ross, Caballero and Cousins30). A social gradient in vitamin status has also been demonstrated, with an increasing level of deficiency associated with lower socio-economic status (SES)(Reference Villamor, Mora-Plazas and Forero29,Reference Chandyo, Ulak and Kvestad31,Reference Wong, Chan and Chui32) .
Evidence on the prevalence of vitamin B12 or folate deficiency is often derived from non-representative surveys with relatively small sample sizes. In Nepal, there is no population-based prevalence data evaluating vitamin B12 and folate status among pregnant women. However, in non-pregnant women aged 15–49 years, the Nepal National Micronutrient Status Survey 2016 reported a folate deficiency in 5 % of the women (erythrocyte folate <226⋅5 nmol/l)(33). Other studies suggest a high prevalence of cobalamin deficiency in Nepal among non-pregnant(Reference Chandyo, Ulak and Sommerfelt34) and pregnant women(Reference Bondevik, Schneede and Refsum35,Reference Jiang, Christian and Khatry36) , while folate deficiency was uncommon(Reference Chandyo, Ulak and Sommerfelt34–Reference Jiang, Christian and Khatry36). However, these studies do not represent recent population data, as most of these studies were performed before 2001. In the present study, we aimed to assess the vitamin B12 and folate status using plasma concentrations of cobalamin, folate and their functional biomarkers, namely tHcy and MMA, among a community-based population of women in early pregnancy from the municipality of Bhaktapur, Nepal. We also aimed to assess investigate both direct and functional biomarkers of vitamin B12 and folate in relation to indicators of SES, and maternal and dietary characteristics.
Study site and population
The study site, Bhaktapur municipality and its surrounding area, lies nearly 15 km east of the capital city of Nepal, Kathmandu. Bhaktapur is an ancient and well-preserved city, settled primarily by the Newar ethnic group. According to the last census in 2011, nearly 82 000 inhabitants resided in Bhaktapur municipality. The population is a predominantly agriculture-based semi-urban community. Many households depend on small business or other daily work and services for additional income. Domestic migrant workers from nearby districts with diverse ethnic backgrounds work seasonally in carpet factories and brick industries within Bhaktapur.
The area is characterised by warm and temperate climate with a hot and wet summer, and a cold and dry winter. The average annual temperature and rainfall are 17⋅9 °C and 1583 mm, respectively(37). While rice is the staple food throughout the year, inhabitants mostly consume locally grown food with vegetables and fruit intake varying in relation to the season. Intake of non-vegetarian foods is common during cultural celebrations and feasts. Factors such as availability of food, varying food prices and workload also determine the food intake of residents.
Eligible women for the study were screened from the community as well as from the study site hospital, the Siddhi Memorial Hospital for women and children, which is a non-governmental community hospital located in Bhaktapur.
Study design and study sample
Data for the present study were gathered from the baseline assessment of an ongoing community-based, individually randomised, double-blinded placebo-controlled trial that intended to assess the effects of daily vitamin B12 supplementation from early pregnancy (<15 weeks of gestation) up to 6 months post-partum on child growth and neurodevelopment. Details of the main study have been published elsewhere(Reference Chandyo, Ulak and Kvestad38). In brief, 800 pregnant women aged 20–40 years, residing in the Bhaktapur municipality and nearby areas, not intending to leave their current settlement for at least 2 years, were targeted for inclusion in the study. Additional inclusion criteria were body mass index (BMI) between 18⋅5 and 30, not chronically ill and under treatment, and no severe anaemia. Vitamin B12 has not yet been recommended for universal use during pregnancy in Nepal, but often medications or nutrient supplements containing vitamin B12 are prescribed for pregnant women. Women were excluded if they were already taking nutrient supplements containing vitamin B12.
If they had not started taking it before enrolment, folic acid was provided to all participants during the first 2 months of pregnancy, and iron and calcium after gestational week 12, as per national guidelines from the Government of Nepal. For the present study, the results of blood sample analyses were available for the first 561 pregnant women enrolled between April 2017 and March 2020.
Socio-demographic information was collected at enrolment through interview. Information on education was categorised into illiterate or primary level (education up to grade 5), secondary level (grade 6–12) and Bachelor's level or above. Ethnic affiliation was grouped into Newar, Brahmin/Chhetri or Gurung/Rai/Magar/Tamang. All other ethnic groups such as Chaudhari, Madhesi, Muslims and Dalit were categorised as others. The Newar ethnic group was chosen as a reference group as it constituted the majority among our study participants (~80 %). Gestational week was estimated from the date of the first day of the last menstrual cycle (LMP method) and ascertained by ultrasound scans. Family type was defined as nuclear if only the parents and the child were living together, and joint or other, if more family members lived in the household. Parity was categorised as primi (having one child), and multi (having two or more children). The mothers were also asked about their age, as well as current smoking and alcohol consumption habits. Occupation was categorised as housewives, working in services (both private and governmental), owning a (small-scale) business, daily wage earners and others which includes those working in agriculture and without formal employment. We asked the mothers if they had or have had any pregnancy-related complaint, such as nausea/vomiting, appetite loss, abdominal pain and dizziness. We dichotomised this variable as complaints and no complaints.
Weight and height were measured using an electronic weighing scale and stadiometer (both seca, Germany). BMI was calculated as body weight (in kg) divided by the square of body height (in m).
Blood sampling and biochemical analyses
At enrolment, i.e. before any supplement had been given, 3 ml of blood were collected into vials containing EDTA as anticoagulant for the study purpose at the field office laboratory. The blood samples were centrifuged at approximately 700 g at room temperature for 10 min; plasma was then separated and collected into three cryovials while cells were transferred separately into another cryovial. All cryovials were labelled and then stored and transported at a maximum of −72 °C in liquid nitrogen, dry ice and ultra-freezers until analysis.
Following blood draw, haemoglobin concentration was analysed immediately using HemoCue (Vedbæk, Denmark), calibrated based on manufacturer's guidelines. Concentrations of plasma cobalamin and folate were assessed by microbiological assays based on a colistin sulphate-resistant strain of Lactobacillus leichmannii (Reference Kelleher and Broin39) and chloramphenicol-resistant strain of Lactobacillus casei (Reference Molloy and Scott40), respectively, adapted to a microtiter format performed by a robotic workstation. Concentrations of the functional biomarkers, plasma tHcy and MMA were analysed using gas chromatography-tandem mass spectrometry based on methylchloroformate derivatisation(Reference Midttun, McCann and Aarseth41). For both cobalamin and folate, the within-day coefficient of variation was 4 %, for tHcy 1 % and MMA 1–4 %. The between-day coefficient of variation was 5 % for cobalamin and folate, 2 % for tHcy and 3–8 % for MMA. Plasma concentrations of cobalamin, folate, tHcy and MMA were analysed at Bevital AS, Bergen, Norway (www.bevital.no).
Definitions of cut-offs
The cut-off value adopted for low cobalamin was <150 pmol/l(Reference Refsum, Yajnik and Gadkari42) and for low folate <10 nmol/l(43). In addition, we report low cobalamin with a cut-off <250 pmol/l as suggested to indicate inadequacy(Reference Allen, Miller and de Groot44). For high tHcy, we used the cut-off value of >10 μmol/l(Reference Aparicio-Ugarriza, Palacios and Alder45), and for high MMA >0⋅26 μmol/l(Reference Bondevik, Schneede and Refsum35,Reference Refsum, Yajnik and Gadkari42,Reference Bolann, Solli and Schneede46) . For anaemia, we report both the commonly used cut-off value of 11 g/dl for haemoglobin, as well as the altitude-adjusted (1400 m) cut-off value of <11⋅3 g/dl(47,Reference Croft, Marshall and Allen48) .
We calculated a combined indicator of vitamin B12 status (3cB12) according to Fedosov et al. (Reference Fedosov, Brito and Miller27), as log(B12/Hcy*MMA), adjusted with the folate and age factor given by Fedosov. For the purpose of the present study, we categorised 3cB12 as <−0⋅5 (vitamin B12 deficiency) and ≥−0⋅5 (vitamin B12 adequacy).
Statistical analyses and justification of sample size
As we used data from an existing study, the sample size was set at 561 women. With this sample size, we could identify the prevalence of a certain nutrient deficiency with a 95 % confidence interval (CI) of not more than ±4 percentage points around a given estimate. In this calculation, we assumed a prevalence of 50 % as this is the most conservative approach; a higher or lower prevalence would result in a higher precision of the estimate.
All data were double entered in a local database and discrepancies and completeness were checked by the data entry supervisor. Data were analysed using Stata, version 16(49). For describing the study sample characteristics, we report mean and standard deviation (sd), median and interquartile range (IQR), or percentage, as appropriate.
We used boxplots to describe the distribution of cobalamin, folate, tHcy, MMA, the combined indicator of cobalamin (3cB12) and haemoglobin, where a red line represents the respective cut-off value in each boxplot. We depicted the relation between cobalamin and its functional biomarkers (tHcy and MMA) using fractional-polynomial prediction plots.
For all indicators used, we built separate bivariable linear regression models with all variables included in Table 1 as independent variables. Folate, tHcy and MMA were not normally distributed (skewness >2) and therefore log-transformed. For the multivariable linear model, we followed the purposeful selection procedure described by Hosmer et al. (Reference Hosmer, Lemeshow and Sturdivant50). If the variables were significantly associated with the outcome in the bivariable models on the basis of a P-value < 0⋅2, they were entered into a multivariable linear regression model simultaneously. Then, we removed the variable with the highest P-value. This step was repeated until all significant variables (P < 0⋅05) were retained in the saturated model. All variables not in the saturated model were then entered again, one by one, and retained if they now were significant (P < 0⋅05).
a N 406, vegetarian was defined as not eating meat and eggs.
b Assessed by the last menstrual period (LMP) method and confirmed by ultrasound scan.
c Usually local rice beer.
The main study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects were approved by the Nepal Health Research Council (NHRC, #253/2016) and the Regional Committee for Medical and Health Research Ethics of Western Norway (2016/1620/REK vest). The study is also registered at clinicaltrials.gov (NCT03071666), and under the Universal Trial Number (U1111-1183-4093). At the implementation site in Bhaktapur, informed written consent was obtained from eligible and willing pregnant women prior to enrolment.
Characteristics of the study cohort
The characteristics of the 561 women included in the present study are shown in Table 1. The women had a mean age of 27⋅5 years (±3⋅8 years), a mean BMI of 23⋅7 (±3⋅0) and a mean gestational week of 11 (±2⋅9 weeks). Less than 2 % of the enrolled women were vegetarian, and less than half of the vegetarian women reported eating eggs. The current pregnancy was the first for 42 % of the women. Twenty-two percent of the women had completed education up to Bachelor's level or above, while nearly 8 % of the mothers were either illiterate or had ended their education before 6th grade.
Medications and health-related complaints
At the time of study enrolment, 69 % of the women had already started folic acid supplementation before the study. Out of 253 participants enrolled at or after gestation week 12, 86 (34 %) had already started iron supplementation as per national guidelines. Approximately 12 % of the women were taking over-the-counter multivitamins or nutrient supplements without vitamin B12 at the time of enrolment. One in five of the participants were taking other medications, such as anti-emetic drugs. Less than 1 % of the women were taking antibiotics at the time of enrolment. Plasma cobalamin concentrations did not differ between those who had started folic acid, iron or multivitamin supplementation at the time of enrolment. However, the mean plasma folate concentration was higher among those taking multivitamins compared with those who were not (78 nmol/l v. 62 nmol/l; t-test, P < 0⋅05).
Approximately one in three women reported pregnancy-related complaints. Nausea and vomiting were the most common complaints (reported by 26 % of all the mothers), followed by loss of appetite (6 %), lower abdominal pain (3 %) and dizziness/vertigo (1 %).
Plasma biomarker profile
The distribution for plasma concentrations of cobalamin, folate, tHcy, MMA and haemoglobin of all study participants (n 561) is illustrated in Fig. 1, and mean plasma concentrations are presented in Table 2. Approximately 24 % of the pregnant women were found to be cobalamin-deficient (plasma cobalamin <150 pmol/l), while the combined indicator (3cB12) indicated a vitamin B12 deficiency among 16 % of the women. One percent of the participants were folate-deficient, and 16 % were anaemic.
a Suboptimal concentration is defined as value above the chosen cut-off for total homocysteine, methylmalonic acid; for all other indicators, it is a value below the indicated cut-off.
Association of cobalamin with functional biomarkers
Fig. 2 illustrates the relation between plasma cobalamin v. tHcy (Panel a) and cobalamin v. MMA (Panel b). Both functional markers show a negative association with plasma cobalamin which appears to be close to linear.
Factors associated with cobalamin and folate
All results from the linear regression analyses are presented in Supplementary Tables S1–S5 of the supplementary material. Fig. 3 illustrates the standardised coefficients (beta) of the variables retained in the final multivariable models.
In the final multivariable model, being a vegetarian was associated with a lower cobalamin concentration (adjusted coefficient −66⋅6; 95 % CI −123⋅9, −9⋅37). The same association was observed for the functional markers, both of which were on average higher in the vegetarian group compared with those eating meat (MMA: 0⋅48; 95 % CI 0⋅04, 0⋅92; tHcy: 0⋅57; 95 % CI 0⋅35, 0⋅79). Having reported pregnancy-related complaints was associated with a higher cobalamin concentration (22⋅5; 95 % CI 7⋅39, 37⋅6). Being affiliated with the ethnic grouping of Gurung/Rai/Magar/Tamang was associated with higher cobalamin compared with the Newar ethnic group (54⋅8; 95 % CI 27⋅4, 82⋅2). Although significant in the bivariable analyses, maternal age, BMI, gestational week, maternal educational level and the frequency of alcohol consumption were no longer significantly associated with cobalamin in the final model (P > 0⋅05).
For folate, being affiliated with the Gurung/Rai/Magar/Tamang ethnic group was associated with a lower plasma concentration (−0⋅31; 95 % CI −0⋅49, −0⋅13). Age (0⋅02; 95 % CI 0⋅006, 0⋅03), gestational week (0⋅02; 95 % CI 0⋅002, 0⋅04) and monthly income (0⋅001; 95 % CI 0⋅0001, 0⋅002) were positively associated with folate status, while having two or more children was associated with a lower mean folate concentration compared with having only one child (−0⋅18; 95 % CI −0⋅30, −0⋅06). Although significant in the bivariable analyses, maternal educational level, occupation group, family type and frequency of alcohol consumption were no longer significantly associated with folate.
In this cross-sectional study investigating cobalamin and folate status among pregnant Nepalese women of gestational age 5–15 weeks, 24 % women were cobalamin-deficient, and 1 % were folate-deficient according to commonly used cut-offs for deficiency.
The status of vitamin B12 among pregnant women in their first trimester in the Bhaktapur district, Nepal, has not previously been assessed in a community-based setting. Among two earlier studies suggesting a high prevalence of cobalamin deficiency among pregnant women, one was hospital based(Reference Bondevik, Schneede and Refsum35), and another was based in a district in the Southern plains of Nepal(Reference Jiang, Christian and Khatry36). Our study suggests that one in four pregnant women in their first trimester was vitamin B12-deficient when using plasma cobalamin as the sole marker for status. In resource-poor settings, diets are often plant-based and low in animal-derived foods due to factors such as high cost, lack of accessibility, availability and impact of cultural or religious beliefs(Reference Allen28). As the main source of vitamin B12 is animal-derived food items, populations in resource-poor settings are especially vulnerable to vitamin B12 deficiency. In similar settings, seasonal shortages of vegetables and fruits, or replacement of these food with low-nutrient dense foods such as polished white rice due to low economic status, has been described as a cause of short-term folate deficiency(Reference Sukumar, Rafnsson and Kandala9). Typically, such deficiency can be relieved quickly without any adverse health effects; however, for women in their first trimester, even short-term shortages of food items high in folate have been shown to severely affect the foetus(Reference Dugdale51). In the hills and mountains of Nepal, common household diets were mostly deficient in vitamin B12 and calcium(Reference Biehl, Klemm and Manohar52). This could explain the relatively high prevalence of cobalamin deficiency shown by our study.
Only 2 % of the participants reported to be vegetarian. In agreement with previous studies(Reference Villamor, Mora-Plazas and Forero29,Reference Ng'eno, Perrine and Whitehead53–Reference Herrmann, Schorr and Obeid55) , these pregnant women were found more likely to have poor vitamin B12 status. However, our findings demonstrate that cobalamin deficiency was not limited to vegetarian women. It has been suggested that even among individuals who do not identify as being vegetarian, consumption of animal-derived food/meat might be limited due to affordability and religious beliefs(Reference Chandyo, Ulak and Sommerfelt34,Reference Yajnik, Deshpande and Lubree54,Reference Antony56) .
Our findings suggest that less than 1 % of the pregnant women were folate-deficient. This is in line with other studies showing that folate deficiency was not common in Nepal, neither in adults(Reference Chandyo, Ulak and Sommerfelt34,Reference Bondevik, Schneede and Refsum35,Reference Jiang, Christian and Khatry36) nor in children(Reference Chandyo, Ulak and Kvestad31,Reference Ng'eno, Perrine and Whitehead53,Reference Stabler57,Reference Ulak, Chandyo and Adhikari58) . The adequate folate status may be attributed to ongoing folic acid supplementation during pregnancy as part of the national nutrition programme, as well as a generally high consumption of foods rich in folate, such as green leafy vegetables(59). Although food intake varies according to the season in this population, we did not see a clear seasonal trend in folate concentration according to timing of the blood draw (data not shown). In our study, two out of every three participating pregnant women had already begun folic acid supplementation as per national guidelines before the time of enrolment. For some women, high plasma folate concentration may be explained by the folate/methyl-trap hypothesis related to vitamin B12 deficiency, intake of oral supplements shortly before blood sampling, or high consumption of foods rich in folate(Reference Allen, Miller and de Groot44,Reference Paul and Selhub60) .
In addition to the direct measures of cobalamin status, we also assessed the functional biomarkers tHcy and MMA(Reference Hannibal, Lysne and Bjørke-Monsen61–Reference Snow65). There was an inverse association between plasma cobalamin concentration and both tHcy and MMA concentration, which has also been described previously(Reference Hannibal, Lysne and Bjørke-Monsen61). In our sample, the prevalence of abnormal values was lower for tHcy (7 %) and higher for MMA (33 %) compared to cobalamin (24 %). Circulating tHcy levels are dependent on the availability of both cobalamin and folate, while MMA is not affected by folate status(Reference Hannibal, Lysne and Bjørke-Monsen61). Folate deficiency was rare in our study participants. In addition, other studies undertaken in Nepal and India have demonstrated that tHcy was not associated with dietary intake or vitamin B12 supplementation in pregnant women(Reference Strand, Ulak and Kvestad21,Reference Duggan, Srinivasan and Thomas66) . Notably however, in the Indian study, vitamin B12 supplementation of the mothers reduced plasma tHcy concentrations in their infants at 6 weeks after birth(Reference Duggan, Srinivasan and Thomas66). This further supports evidence suggesting that tHcy may not be a good indicator of vitamin B12 status during pregnancy. MMA is considered a more specific marker of cobalamin function(Reference Bolann, Solli and Schneede46,Reference Clarke, Refsum and Birks67) and may help explain the differences in prevalence that we observed. However, MMA might have been altered to a larger extend by intestinal bacterial overgrowth and infection(Reference Allen, Miller and de Groot44). We did not have data to support this. To increase the precision of diagnosing cobalamin deficiency, Fedosov et al. (Reference Fedosov, Brito and Miller27) suggested the use of an indicator combining several biomarkers of vitamin B12, with additional adjustment for age and folate status. Using their formula for the combined cobalamin indicator (3cB12), the prevalence of cobalamin deficiency was 16 % in our study sample. A lower prevalence of low vitamin B12 status measured by the 3cB12 indicator (47 %) compared with plasma vitamin B12 (<148 pmol/l) (63 %) has also been reported in a group of pregnant women at 12 weeks of gestations in India(Reference Finkelstein, Fothergill and Krisher68). However, to our knowledge, the use of the combined indicator is yet to be validated among pregnant women and reasons for the discrepancy between indicators remain unclear.
A deficiency of cobalamin and folate may result in anaemia, as both are required for erythropoiesis(Reference Koury and Ponka4,Reference Stabler5) . In our study, 16 % of the pregnant women were anaemic according to a haemoglobin cut-off at 11⋅3 g/dl (altitude-adjusted) and 10⋅5 % with a cut-off at 11 g/dl. The Nepal Micronutrient Status Survey 2016 suggested a higher prevalence of anaemia among pregnant women of nearly 27 % when using 11 g/dl of haemoglobin as cut-off(33). The higher prevalence in the national sample could be attributed to differences in gestational age, maternal age and sampling location. In the present study, cobalamin deficiency was not associated with anaemia, in concurrence with an earlier study performed in the same setting among non-pregnant women(Reference Chandyo, Ulak and Sommerfelt34).
In our study, pregnancy-related complaints were associated with a higher mean concentration of plasma cobalamin. The interpretation of this observation is hindered by the non-specific categorisation of all complaints into a single group. Nonetheless, the finding appears somewhat counterintuitive, as lower food intake and subsequently lower cobalamin status would be expected to occur as a result of pregnancy-related complaints such as vomiting and nausea. However, Nepali women could have taken ready-made and fortified foods to compensate the potential nutrient loss due to hyperemesis gravidum. We did not adjust the analysis for dietary intake and thus, cannot confirm this.
Higher SES was associated with better cobalamin and folate status in our analysis; this is in line with findings from a study of infants living in the same area(Reference Chandyo, Ulak and Kvestad31) and has been repeatedly documented in other studies(Reference Allen28). Diets of populations with a low SES are typically low in vitamin B12, due to higher prices and lower availability of animal-derived foods. These populations are also characterised by a higher disease burden, which can increase nutrient requirements and impair the nutrient absorption(Reference Allen28).
Although Smith(Reference Smith69) states that differences in food intake might better be described by means of income than cultural restrictions, in our study, ethnic affiliation was consistently associated with vitamin B12 and folate status, even when other indicators of SES were included in the regression models. This could indicate that in addition to differences in SES and thus economic opportunities and access to health care, cultural practices which indicate a more varied diet and/or a more frequent consumption of non-vegetarian diets could be important.
Strengths and limitations
The key strength of the present study is the comprehensive characterisation of a large community-based cohort of women sampled in early pregnancy. In addition, standard procedures were followed for blood sample collection, storage and transfer, ensuring optimal cold chain, and state-of-the-art biochemical methods were used to estimate biomarker concentrations. During pregnancy, cobalamin and folate requirements in the body increase; however, unfortunately, we did not have data on dietary intake at the time point of enrolment. To our knowledge, there are no specific, universally accepted cut-off values for markers of vitamin B12 in early pregnancy. It has been shown that concentrations of B12 biomarkers decline during pregnancy, among others due to hemodilution. However, different cut-off during pregnancy have not been agreed upon, and cut-offs for the general population are commonly used. This is seen in a recent meta-analyses including twelve studies during the first trimester, where eight of the studies used cut-offs between 148 and 156 pmol/l(Reference Sukumar, Rafnsson and Kandala9). The increase in plasma volume during pregnancy is not expected to start before 6–10 weeks(Reference Faupel-Badger, Hsieh and Troisi70), and thus, the effect of hemodilution on the prevalence of low B12 in participants of the present study, measured on average at 11 weeks of gestation, is expected to be minimal.
The prevalence of cobalamin deficiency in our study population of women in early pregnancy living in Bhaktapur, Nepal, was 24 %. In contrast, folate deficiency was rare. In light of the high levels of cobalamin deficiency observed in the present study, future studies are needed to assess the potential functional consequences of suboptimal maternal cobalamin status such as complications and adverse outcomes in pregnancy as well as long-term outcomes such as impaired postnatal growth and cognitive development.
The supplementary material for this article can be found at https://doi.org/10.1017/jns.2021.53.
This work was supported by the Research Council of Norway through its Centres of Excellence scheme (project number 223269) and the University of Bergen (UiB), Norway, to the Centre for Intervention Science in Maternal and Child Health (CISMAC).
Conception/design of the work: C. S., S. S., R. K. C. and T. A. S.; Data acquisition: S. S., R. K. C., M. U., S. R., M. S. and T. A. S.; Analysis of blood samples: A. M. and P. M. U.; Data analysis: C. S. and S. S.; Data interpretation: C. S. and S. S.; Drafted the manuscript: C. S. and S. S.; Substantially revised the manuscript: R. K. C., M. U., M. H., I. K., S. R., M. S. and T. A. S.; All authors read and approved the submitted version.
The authors declare that they have no conflict of interest.